newsfilter
← Latest News
GlobeNewswire·

Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025

NEWTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic